| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72319-022-02 | 72319-022 | HUMAN PRESCRIPTION DRUG | RANOLAZINE | RANOLAZINE | TABLET, FILM COATED, EXTENDED RELEASE | ORAL | 20220615 | N/A | ANDA | ANDA213517 | i3 Pharmaceuticals, LLC | RANOLAZINE | 1000 mg/1 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72319-022-02) |
| 72319-021-02 | 72319-021 | HUMAN PRESCRIPTION DRUG | RANOLAZINE | RANOLAZINE | TABLET, FILM COATED, EXTENDED RELEASE | ORAL | 20220615 | N/A | ANDA | ANDA213517 | i3 Pharmaceuticals, LLC | RANOLAZINE | 500 mg/1 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72319-021-02) |